Literature DB >> 35254150

Minimally Adequate Treatment for Depression and Anxiety Associated With Mortality in Primary Care Older Adults.

Helen-Maria Vasiliadis1, Catherine Lamoureux-Lamarche1, Sébastien Grenier2, Pasquale Roberge3.   

Abstract

OBJECTIVE: To assess the association between receipt of minimally adequate treatment (MAT) and mortality in a sample of community primary care older adults with depression and anxiety.
METHOD: The present study was conducted among a sample of 358 older adults ( ≥ 65 years old) with depression or an anxiety disorder recruited in primary care practices between 2011 and 2013. Participants agreed to link their health survey and administrative data for the 3 years preceding and following the baseline interview. Depression and anxiety disorders were based on self-reported symptoms aligned with DSM-5 criteria and physician diagnoses (International Classification of Diseases [ICD], 9th and 10th revisions). MAT was defined according to Canadian guidelines and include receipt of pharmacotherapy and ≥ 4 medical visits within 3 months or a number of psychotherapy sessions (individual, group, or family) over 12 months (depression: ≥8; anxiety disorders: ≥5 to 7). All-cause 3-year mortality was ascertained from the vital statistics death registry in Québec. Propensity score weighted regression analysis was conducted to assess the association between receipt of MAT and mortality adjusting for individual, clinical, and health system study factors.
RESULTS: Receipt of MAT was associated with a reduced risk of mortality (hazard ratio [HR]: 0.27; 95% confidence interval [95% CI], 0.12 to 0.62). Individual and clinical factors associated with increased mortality included older age, male sex, being single, low functional status, and increased physical disorders and cognitive functioning. Lifestyle factors associated with reduced and increased mortality included alcohol consumption and smoking, respectively. Health system factors such as perceived adequate number of visits to speak to the doctor about emotional problems and continuity of care were associated with reduced mortality.
CONCLUSION: The current study highlights the important role of primary care physicians in detecting and providing MAT for older adults with depression and anxiety, as this may have an effect on longevity.

Entities:  

Keywords:  anxiety disorders; depression; minimally adequate care; mortality; older adults; primary care

Mesh:

Year:  2022        PMID: 35254150      PMCID: PMC9449137          DOI: 10.1177/07067437221082883

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   5.321


  50 in total

1.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

2.  Mortality in mental health patients of the Emilia-Romagna region of Italy: A registry-based study.

Authors:  Domenico Berardi; Elisa Stivanello; Federico Chierzi; Muriel Assunta Musti; Vincenza Perlangeli; Paolo Pandolfi; Antonella Piazza; Alessio Saponaro; Michele Sanza; Mila Ferri; Marco Menchetti; Angelo Fioritti
Journal:  Psychiatry Res       Date:  2021-01-02       Impact factor: 3.222

3.  Prevalence of mental disorders in elderly people: the European MentDis_ICF65+ study.

Authors:  Sylke Andreas; Holger Schulz; Jana Volkert; Maria Dehoust; Susanne Sehner; Anna Suling; Berta Ausín; Alessandra Canuto; Mike Crawford; Chiara Da Ronch; Luigi Grassi; Yael Hershkovitz; Manuel Muñoz; Alan Quirk; Ora Rotenstein; Ana Belén Santos-Olmo; Arieh Shalev; Jens Strehle; Kerstin Weber; Karl Wegscheider; Hans-Ulrich Wittchen; Martin Härter
Journal:  Br J Psychiatry       Date:  2016-09-08       Impact factor: 9.319

Review 4.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly.

Authors:  Glenda M MacQueen; Benicio N Frey; Zahinoor Ismail; Natalia Jaworska; Meir Steiner; Ryan J Van Lieshout; Sidney H Kennedy; Raymond W Lam; Roumen V Milev; Sagar V Parikh; Arun V Ravindran
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

5.  A Surveillance System to Monitor Excess Mortality of People With Mental Illness in Canada.

Authors:  Alain Lesage; Louis Rochette; Valérie Émond; Éric Pelletier; Danielle St-Laurent; Fatoumata Binta Diallo; Stephen Kisely
Journal:  Can J Psychiatry       Date:  2015-12       Impact factor: 4.356

6.  Accumulation Of Chronic Conditions At The Time Of Death Increased In Ontario From 1994 To 2013.

Authors:  Laura Rosella; Kathy Kornas; Anjie Huang; Catherine Bornbaum; David Henry; Walter P Wodchis
Journal:  Health Aff (Millwood)       Date:  2018-03       Impact factor: 6.301

7.  Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial.

Authors:  Martha L Bruce; Thomas R Ten Have; Charles F Reynolds; Ira I Katz; Herbert C Schulberg; Benoit H Mulsant; Gregory K Brown; Gail J McAvay; Jane L Pearson; George S Alexopoulos
Journal:  JAMA       Date:  2004-03-03       Impact factor: 56.272

8.  Quality of depression care and its impact on health service use and mortality among veterans.

Authors:  Jeffrey A Cully; Meghan Zimmer; Myrna M Khan; Laura A Petersen
Journal:  Psychiatr Serv       Date:  2008-12       Impact factor: 3.084

9.  The Factors Associated with 3-Year Mortality Stratified by Physical and Mental Multimorbidity and Area of Residence Deprivation in Primary Care Community-Living Older Adults.

Authors:  Helen-Maria Vasiliadis; Samantha Gontijo Guerra; Djamal Berbiche; Isabelle E Pitrou
Journal:  J Aging Health       Date:  2021-03-27
View more
  1 in total

1.  Health care system and patient costs associated with receipt of minimally adequate treatment for depression and anxiety disorders in older adults.

Authors:  Catherine Lamoureux-Lamarche; Djamal Berbiche; Helen-Maria Vasiliadis
Journal:  BMC Psychiatry       Date:  2022-03-10       Impact factor: 3.630

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.